Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityLeukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formataffinity purified
Size0.01 mg, 0.02 mg, 0.05 mg
Concentration200ug/ml
ApplicationsImmunocytochemistry (ICC), Immunohistochemistry (IHC) - Formalin/Paraffin, ELISA (EIA), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody is a rabbit polyclonal antibody raised against LILRA3. It has been selected for its ability to recognize LILRA3 in immunohistochemical staining andwestern blotting.
ImmunogenImmunogen: Recombinant LILRA3 (Val219~Gly438) expressed in E.coli.
Other Names[leukocyte immunoglobulin-like receptor subfamily A member 3 isoform 2; Leukocyte immunoglobulin-like receptor subfamily A member 3; leukocyte immunoglobulin-like receptor subfamily A member 3; leukocyte immunoglobulin like receptor A3; CD85 antigen-like family member E; Immunoglobulin-like transcript 6; ILT-6; Leukocyte immunoglobulin-like receptor 4; LIR-4; Monocyte inhibitory receptor HM43/HM31; CD_antigen: CD85e]
Gene, Accession #[LILRA3], Gene ID: 11026, NCBI: NP_001166125.1, UniProt: Q8N6C8
Catalog #MBS2016782
Price$105, $125, $170
Order / More InfoLeukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.